B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal Disease

McArthur, 1993, Specific antibodies and their potential role in periodontal diseases, J Periodontol, 64, 807, 10.1902/jop.1993.64.8s.807

Taubman, 1982, 283

Ebersole, 1987, Human serum antibody responses to oral microorganisms. IV. Correlation with homologous infection, Oral Microbiol Immunol, 2, 53, 10.1111/j.1399-302X.1987.tb00290.x

Wu, 2005, RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts, J Bone Miner Res, 20, 107, 10.1359/JBMR.041022

Hofbauer, 2000, The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption, J Bone Miner Res, 15, 2, 10.1359/jbmr.2000.15.1.2

Kong, 1999, Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development, Immunol Cell Biol, 77, 188, 10.1046/j.1440-1711.1999.00815.x

Kong, 1999, Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, 402, 304, 10.1038/46303

Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658

Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3

Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X

Mackler, 1977, Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease, J Periodontal Res, 12, 37, 10.1111/j.1600-0765.1977.tb00107.x

Seymour, 1979, The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease, J Periodontal Res, 14, 39, 10.1111/j.1600-0765.1979.tb00216.x

Taubman, 1984, Phenotypic studies of cells from periodontal disease tissues, J Periodontal Res, 19, 587, 10.1111/j.1600-0765.1984.tb01320.x

Okada, 1983, Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis, Infect Immun, 41, 365, 10.1128/IAI.41.1.365-374.1983

Yamazaki, 1993, Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease, J Periodontal Res, 28, 324, 10.1111/j.1600-0765.1993.tb01076.x

Seymour, 1997, CD29 expression on CD4+ gingival lymphocytes supports migration of activated memory T lymphocytes to diseased periodontal tissue, Oral Microbiol Immunol, 12, 129, 10.1111/j.1399-302X.1997.tb00368.x

Valverde, 2004, Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease, J Bone Miner Res, 19, 155, 10.1359/jbmr.0301213

Valverde, 2005, Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease, J Dent Res, 84, 488, 10.1177/154405910508400603

Teng, 2000, Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection, J Clin Invest, 106, R59, 10.1172/JCI10763

Croucher, 2001, Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma, Blood, 98, 3534, 10.1182/blood.V98.13.3534

Choi, 2001, Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells, Eur J Immunol, 31, 2179, 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X

Han, 2006, Bacterial-responsive B lymphocytes induce periodontal bone resorption, J Immunol, 176, 625, 10.4049/jimmunol.176.1.625

Takeichi, 2000, Cytokine profile of T lymphocytes from gingival tissues with pathological pocketing, J Dent Res, 79, 1548, 10.1177/00220345000790080401

Kawai, 1999, Selective diapedesis of Th1 cells induced by endothelial cell RANTES, J Immunol, 163, 3269, 10.4049/jimmunol.163.6.3269

Hofbauer, 1999, Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis, Endocrinology, 140, 4382, 10.1210/endo.140.10.7034

Smith, 1985, Gingival crevicular fluid antibody to oral microorganisms. III. Association of gingival homogenate and gingival crevicular fluid antibody levels, J Periodontal Res, 20, 357, 10.1111/j.1600-0765.1985.tb00447.x

Kawai, 1998, A novel approach for detecting an immunodominant antigen of Porphyromonas gingivalis in diagnosis of adult periodontitis, Clin Diagn Lab Immun, 5, 11, 10.1128/CDLI.5.1.11-17.1998

Ebersole, 1980, An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans, J Periodontal Res, 15, 621, 10.1111/j.1600-0765.1980.tb00321.x

Chen, 1998, Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen, J Bone Miner Res, 13, 1112, 10.1359/jbmr.1998.13.7.1112

Kawai, 2000, Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease, J Immunol, 164, 2102, 10.4049/jimmunol.164.4.2102

Boyle, 2001, 489

Boyle, 2001, 1691

Min, 2000, Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis, J Exp Med, 192, 463, 10.1084/jem.192.4.463

Dougall, 1999, RANK is essential for osteoclast and lymph node development, Genes Dev, 13, 2412, 10.1101/gad.13.18.2412

Mizuno, 1998, Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin, Biochem Biophys Res Commun, 247, 610, 10.1006/bbrc.1998.8697

Hofbauer, 2004, The OPG/RANKL/RANK system in metabolic bone diseases, J Musculoskel Neuronal Interact, 4, 268

Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852

Nagasawa, 2002, LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin, Clin Exp Immunol, 130, 338, 10.1046/j.1365-2249.2002.01990.x

Mogi, 2004, Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis, J Dent Res, 83, 166, 10.1177/154405910408300216

Murray, 1989, Antibodies to Bacteroides gingivalis in patients with treated and untreated periodontal disease, J Periodontol, 60, 96, 10.1902/jop.1989.60.2.96

Sakata, 1999, Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells, J Bone Miner Res, 14, 1486, 10.1359/jbmr.1999.14.9.1486

Yu, 2004, CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts, J Bone Miner Res, 19, 2065, 10.1359/jbmr.040910

Roodman, 2004, MIP-1 alpha and myeloma bone disease, Cancer Treat Res, 118, 83, 10.1007/978-1-4419-9129-4_4

Bendre, 2005, Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway, Cancer Res, 65, 11001, 10.1158/0008-5472.CAN-05-2630

Gainet, 1999, Neutrophil dysfunctions, IL-8, and soluble L-selectin plasma levels in rapidly progressive versus adult and localized juvenile periodontitis: variations according to disease severity and microbial flora, J Immunol, 163, 5013, 10.4049/jimmunol.163.9.5013

Kobayashi, 2000, Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction, J Exp Med, 191, 275, 10.1084/jem.191.2.275

Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr Rev, 20, 345, 10.1210/edrv.20.3.0367

Teitelbaum, 2000, Bone resorption by osteoclasts, Science, 289, 1504, 10.1126/science.289.5484.1504

Goldring, 2000, Pathogenesis of bone erosions in rheumatoid arthritis, Curr Opin Rheumatol, 12, 195, 10.1097/00002281-200005000-00006

Xu, 1995, Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system, J Cell Physiol, 165, 624, 10.1002/jcp.1041650321

Gorny, 2004, IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro, Exp Cell Res, 294, 149, 10.1016/j.yexcr.2003.11.009

Horwood, 2001, IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro, J Immunol, 166, 4915, 10.4049/jimmunol.166.8.4915

Yamada, 2002, Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity, Bone, 30, 901, 10.1016/S8756-3282(02)00722-6

Wei, 2005, IL-1 mediates TNF-induced osteoclastogenesis, J Clin Invest, 115, 282, 10.1172/JCI200523394

Walsh, 2005, Rheumatic diseases: the effects of inflammation on bone, Immunol Rev, 208, 228, 10.1111/j.0105-2896.2005.00338.x

Assuma, 1998, IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis, J Immunol, 160, 403, 10.4049/jimmunol.160.1.403

Madianos, 2005, Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva, J Clin Periodontol, 32, 57, 10.1111/j.1600-051X.2005.00821.x

Page, 1986, Gingivitis, J Clin Periodontol, 13, 345, 10.1111/j.1600-051X.1986.tb01471.x

Tanaka, 2005, Osteoblasts and osteoclasts in bone remodeling and inflammation, Curr Drug Targets Inflamm Allergy, 4, 325, 10.2174/1568010054022015